# Evolutionary Restructuring and Systematic Review of the NBPF Gene Family: Comparative Genomics, Functional Divergence, and Disease-Linked Pathways

**Authors:** Manuel Escalona, Rosa Roy

PMC · DOI: 10.3390/jdb14010010 · Journal of Developmental Biology · 2026-02-24

## TL;DR

This study explores the evolution and function of the NBPF gene family, focusing on its origins, structure, and potential roles in human biology and disease.

## Contribution

The paper provides a comprehensive phylogenetic reconstruction and systematic review of the NBPF gene family, proposing its evolutionary origin from PDE4DIP.

## Key findings

- NBPF likely originated from duplication of PDE4DIP, with NBPF26 as the ancestral member.
- Lineage-specific duplications led to divergence of NBPF genes in humans.
- NBPF genes are linked to cell proliferation and development, especially in neural and skeletal tissues.

## Abstract

The Neuroblastoma Breakpoint Family (NBPF) consists of 23 genes, 9 of which are pseudogenes, and is characterized by extensive duplication events and species-specific diversification in Homo sapiens, as well as by the presence of a unique protein domain known as Olduvai (also referred to as DUF1220 or the NBPF domain). Previous studies have attempted to define subfamilies based on the presence of HLS triplet domains; however, this classification has become increasingly unclear with the identification of additional NBPF members. The family remains poorly understood, and the functions of many genes are still unknown, although several have been hypothesized to play key roles in cell proliferation and developmental processes, particularly in neural and skeletal tissues. In this study, we systematically analyzed all available data on the NBPF gene family using the PRISMA-S methodology to infer the biological functions in which these genes may be involved. We also generated multiple phylogenetic trees to support the creation of coherent subfamilies and to correlate the origin of each subfamily with homologous genes in our last common ancestor with the Pan genus, providing what we believe to be one of the most comprehensive phylogenetic reconstructions including all currently annotated NBPF members. Through comparative genomic and phylogenetic analyses, we propose that the NBPF may have originated from a duplication of the PDE4DIP gene, with NBPF26 representing the ancestral member from which the remaining NBPF genes diverged via lineage-specific segmental duplications. In this systematic review and comparative genomic study, we present the first integrative synthesis of our knowledge of the NBPF, encompassing its evolutionary origins, structural dynamics, expression across tissues, and clinical associations.

## Linked entities

- **Genes:** NBPF14 (NBPF member 14) [NCBI Gene 25832], PDE4DIP (phosphodiesterase 4D interacting protein) [NCBI Gene 9659], NBPF26 (NBPF member 26) [NCBI Gene 101060684]
- **Species:** Homo sapiens (taxon 9606), Pan (taxon 9596)

## Full-text entities

- **Genes:** NBPF5P (NBPF member 5, pseudogene) [NCBI Gene 100507044] {aka DKFZp434D177-like, NBPF5}, CLU (clusterin) [NCBI Gene 1191] {aka AAG4, APO-J, APOJ, CLI, CLU1, CLU2}, AKT1S1 (AKT1 substrate 1) [NCBI Gene 84335] {aka Lobe, PRAS40}, HYLS1 (HYLS1 centriolar and ciliogenesis associated) [NCBI Gene 219844] {aka HLS}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, NBPF13P (NBPF member 13, pseudogene) [NCBI Gene 644861], NUP98 (nucleoporin 98 and 96 precursor) [NCBI Gene 4928] {aka ADIR2, NUP196, NUP96, Nup98-96}, NBPF2P (NBPF member 2, pseudogene) [NCBI Gene 343381], NBPF9 (NBPF member 9) [NCBI Gene 400818] {aka AE01}, NBPF7P (NBPF member 7, pseudogene) [NCBI Gene 343505] {aka NBPF7}, NBPF26 (NBPF member 26) [NCBI Gene 101060684], PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, LHX3 (LIM homeobox 3) [NCBI Gene 8022] {aka CPHD3, LIM3, M2-LHX3}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, CDKN1A (cyclin dependent kinase inhibitor 1A) [NCBI Gene 1026] {aka CAP20, CDKN1, CIP1, MDA-6, P21, SDI1}, NBPF14 (NBPF member 14) [NCBI Gene 25832] {aka AE5, DJ328E19.C1.1, NBPF}, S100P (S100 calcium binding protein P) [NCBI Gene 6286] {aka MIG9}, NBPF12 (NBPF member 12) [NCBI Gene 149013] {aka COAS1, KIAA1245}, KIF7 (kinesin family member 7) [NCBI Gene 374654] {aka ACLS, AGBK, HLS2, JBTS12, MMEDF, UNQ340}, FURIN (furin, paired basic amino acid cleaving enzyme) [NCBI Gene 5045] {aka FUR, PACE, PCSK3, SPC1}, NBPF3 (NBPF member 3) [NCBI Gene 84224] {aka AE2}, NBPF22P (NBPF member 22, pseudogene) [NCBI Gene 285622], KIF1B (kinesin family member 1B) [NCBI Gene 23095] {aka CMT2, CMT2A, CMT2A1, HMSNII, KLP, NBLST1}, NBPF19 (NBPF member 19) [NCBI Gene 101060226], CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, NOTCH2NLA (notch 2 N-terminal like A) [NCBI Gene 388677] {aka N2N, NOTCH2NL}, NOTCH2 (notch receptor 2) [NCBI Gene 4853] {aka AGS2, HJCYS, hN2}, AFP (alpha fetoprotein) [NCBI Gene 174] {aka AFPD, FETA, HPAFP}, NBPF18P (NBPF member 18, pseudogene) [NCBI Gene 441908], CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, NBPF25P (NBPF member 25, pseudogene) [NCBI Gene 101929780] {aka WI2-925H4.1}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, NBPF20 (NBPF member 20) [NCBI Gene 100288142], PDE4DIP (phosphodiesterase 4D interacting protein) [NCBI Gene 9659] {aka CMYA2, MMGL}, NBPF1 (NBPF member 1) [NCBI Gene 55672] {aka AB13, AB14, AB23, AD2, NBG, NBPF}, ASIC2 (acid sensing ion channel subunit 2) [NCBI Gene 40] {aka ACCN, ACCN1, ASIC2a, BNC1, BNaC1, MDEG}, RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970] {aka AIF3BL3, CMCU, NFKB3, p65}, NBPF8 (NBPF member 8) [NCBI Gene 728841] {aka NBPF8P}, NBPF3 (NBPF member 3) [NCBI Gene 456599] {aka NBPF}, NBPF21P (NBPF member 21, pseudogene) [NCBI Gene 205655], NBPF10 (NBPF member 10) [NCBI Gene 100132406] {aka AB6, AG1}, NBPF15 (NBPF member 15) [NCBI Gene 284565] {aka AB14, AG3, NBPF16}, MUC4 (mucin 4, cell surface associated) [NCBI Gene 4585] {aka ASGP, HSA276359, MUC-4}, NBPF11 (NBPF member 11) [NCBI Gene 200030] {aka NBPF24}, NBPF17P (NBPF member 17, pseudogene) [NCBI Gene 401967] {aka NBPF23, NBPF23P}
- **Diseases:** sudden cardiac death (MESH:D016757), congenital disorder (MESH:D009358), LUAD (MESH:D000077192), ovarian cystic teratomas (MESH:C562731), neuroblastoma (MESH:D009447), ACC (MESH:D018268), GBM (MESH:D005909), neurological pathologies (MESH:D005598), bipolar disorder (MESH:D001714), neoplasms (MESH:D009369), Mayer-Rokitansky-Kuster-Hauser Syndrome (MESH:C537371), polycystic ovary syndrome (MESH:D011085), developmental malformation (MESH:C564254), osteogenesis (MESH:D010013), BRCA (MESH:D001943), neurological disorders (MESH:D009461), LNM (MESH:D008207), SCC (MESH:D018288), LUSC (MESH:D002294), congenital heart disease (MESH:D006330), acute lymphoblastic leukemia (MESH:D054198), Bone Growth Disorders (MESH:D006130), inflammatory disease (MESH:D007249), non-Hodgkin B-cell lymphoma (MESH:D016393), congenital disease (MESH:D030342), schizophrenia (MESH:D012559), ADC (MESH:D000230), sensorineural hearing loss (MESH:D006319), PDAC (MESH:D021441), insulin resistance (MESH:D007333), congenital malformations (OMIM:163000), injury to (MESH:D014947), mixed ductal carcinoma (MESH:D044584), developmental delay (MESH:D002658), TAPVC (MESH:D012587), metastasis (MESH:D009362), AML (MESH:D015470), autism (MESH:D001321), myalgic encephalomyelitis/chronic fatigue syndrome (MESH:D015673), T2DM (MESH:D003924), triple-negative breast cancer (MESH:D064726), macrocephaly (MESH:D058627), craniofacial dysmorphism (MESH:C537512), neurological, oncogenic, and skeletal disorders (MESH:D000074723), NIID (MESH:C537395), oncogenesis (MESH:D063646), bone malformations (MESH:D001847), MPLC (MESH:D008175), T1DM (MESH:D003922), vaginal agenesia (MESH:D014627), and microcephaly (MESH:D008831), hepatocellular carcinoma (MESH:D006528), dermatological disease (MESH:D000168), hypertelorism (MESH:D006972), cognitive disease (MESH:D003072), cervical cancer (MESH:D002583), inflammatory response (MESH:D018746), CRC (MESH:D015179), endocrine system disorders (MESH:D004700), thymoma (MESH:D013945)
- **Chemicals:** lithium (MESH:D008094)
- **Species:** Human endogenous retrovirus K (species) [taxon 45617], Hominidae (great apes, family) [taxon 9604], Erinaceidae (hedgehogs, family) [taxon 9363], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986], Pseudomonas sp. AN (species) [taxon 534632], Chiroptera (bats, order) [taxon 9397], Otolemur garnettii (small-eared galago, species) [taxon 30611], Macaca fascicularis (crab eating macaque, species) [taxon 9541], Astyanax mexicanus (blind cave fish, species) [taxon 7994], Mus musculus (house mouse, species) [taxon 10090], Galago sp. (bush baby, species) [taxon 9464], Homo sapiens (human, species) [taxon 9606], Pan troglodytes (chimpanzee, species) [taxon 9598]
- **Mutations:** rs3897177, p.L279W, 369 G > A, rs200632836, T2T, rs1553120233
- **Cell lines:** HaCaT — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0038)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13028154/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13028154/full.md

## References

57 references — full list in the complete paper: https://tomesphere.com/paper/PMC13028154/full.md

---
Source: https://tomesphere.com/paper/PMC13028154